NICOLE MATTISON: Open Payments
NPI 1366859365 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 31 payments from 11 companies in 2025. Trend: 2023 $778 · 2024 $504 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| Merck Sharp & Dohme LLC | 6 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| PFIZER INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
Products named: VERQUVO, FARXIGA, LEQVIO, Kerendia, LifeVest, Wegovy, ONPATTRO, ELIQUIS.
Industry payments across KS — which companies pay providers there.
